Liddy Chen

Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

James L. Gulley, Michael Borre, Nicholas J. Vogelzang et al. · Journal of Clinical Oncology · 2019 · 278 citations · Full text

Medicine, Immunology, Oncology +17

Patients readmitted to the intensive care unit during the same hospitalization

Liddy Chen, Claudio M. Martin, Sean Keenan et al. · Critical Care Medicine · 1998 · 170 citations

Medicine, Clinical Sciences, Critical Care Medicine +10

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt et al. · The Journal of Infectious Diseases · 2022 · 53 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Assessing Communication Between Oncology Professionals and Their Patients

Cleora S. Roberts, Harold Benjamin, Liddy Chen et al. · Journal of Cancer Education · 2005 · 38 citations

Nursing, Communication, Oncology +14

Results of PROSPECT: A randomized phase 3 trial of PROSTVAC-V/F (PRO) in men with asymptomatic or minimally symptomatic metastatic, castration-resistant prostate cancer.

James L. Gulley, Michael Borre, Nicholas J. Vogelzang et al. · Journal of Clinical Oncology · 2018 · 16 citations

Veterinary Medicine, Oncology, Translational Sciences +17